Search results
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Benzinga via Yahoo Finance· 4 days agoWednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...
CDC Found Evidence COVID-19 Vaccines Caused Deaths
WSAU Wausau· 4 days agoIn an exclusive report by the Epoch Times, U.S. Centers for Disease Control and Prevention (CDC) officials fou...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 4 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
TIME100 Health: Katalin Kariko and Drew Weissman
Time Magazine· 3 days agoDr. Drew Weissman was working on developing an HIV vaccine, and Katalin Kariko was struggling to keep her lab open and convince her superiors that her...
Study identifies immunity threshold for protection against COVID-19 in children
Medical Xpress· 5 days agoAll participants received two doses of 10mcg Pfizer/BioNTech mRNA COVID-19 vaccination, 21 days apart. The team followed up with the participants for one year, during which ...
The CDC Took Out 148 Pages of Essential Information
Mercola· 3 days agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of the outer lining of the heart. The public ...
DP Technology DevDay 2024 Showcases Large Science Models and Announces Open Science Initiative
WTNH-TV New Haven· 6 days agoIn recent years, the rapid development of artificial intelligence has introduced new possibilities...
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook - GSK (NYSE:GSK)
Benzinga· 4 days agoVaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand...
Why are nearly half of all recent biotech RNA alliances in Asia-Pacific betting big on...
BioPharma-Reporter· 5 days agoAlmost half of all strategic alliances focused on RNA therapies over the last five years in the...